X4 Pharmaceuticals Inc.

NASDAQ: XFOR · Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT

X4 Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-37.45M -101.17M -93.87M -88.7M
Depreciation & Amortization
796K 419K 513K 499K
Stock-Based Compensation
8.2M 8.69M 5.2M 6.18M
Other Working Capital
6.85M -890K 2.31M -2.66M
Other Non-Cash Items
-105.13M -4.79M 5.32M 19.29M
Deferred Income Tax
n/a n/a n/a -6.68M
Change in Working Capital
2.67M 344K 5.74M -1.5M
Operating Cash Flow
-130.9M -96.51M -77.1M -70.91M
Capital Expenditures
-326K -60K -103K -615K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-57.13M -16.82M -4.8M n/a
Sales Maturities Of Investments
26.45M 2M n/a n/a
Other Investing Acitivies
98M n/a 4.8M n/a
Investing Cash Flow
66.99M -14.88M -103K -615K
Debt Repayment
20M 20.44M -795K n/a
Common Stock Repurchased
n/a n/a n/a -2M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 8.08M -4.61M 260K
Financial Cash Flow
20.29M 88.52M 117.23M 74.25M
Net Cash Flow
-43.77M -22.78M 39.92M 2.41M
Free Cash Flow
-131.23M -96.57M -77.2M -71.52M